Document:

Unassociated Document

    AMENDMENT TO EMPLOYMENT AND
NON-COMPETITION AGREEMENT

    

    This Amendment to Employment and
Non-Competition Agreement (this “Amendment”) is entered into between Encompass
Group Affiliates, Inc., f/k/a Advanced Communications Technologies, Inc., a
Florida corporation (“Employer”), and Steven J. Miller, an individual whose
address is 2248 Home Again Road, Apopka, FL 32712 (“Executive”), effective as of
July 31, 2009.

    

    BACKGROUND

    

    Employer and Executive are party to an
Employment Agreement dated as of August 17, 2007 (the “Employment Agreement”),
which sets forth the terms and conditions of Executive’s employment with
Employer.  Employer and Executive wish to amend the terms of the
Employment Agreement as set forth herein, and, hereafter, references to the
“Employment Agreement,” “Agreement,” “herein,” or words of like import in the
Employment Agreement shall refer to the Employment Agreement as amended
hereby.

    

    NOW, THEREFORE, in consideration of the
premises and the mutual agreements contained herein and intending to be legally
bound hereby, the parties hereto agree as follows:

    

    1.           All
capitalized terms used herein and not defined herein shall have the respective
meanings assigned to them in the Employment Agreement.

    

    2.           Paragraph
(d) of Schedule 1 of the Employment Agreement, containing the definition of
“Performance Bonus,” is hereby deleted in its entirety and replaced with the
following:

    

    “Performance Bonus” means, with respect
to any fiscal year of Encompass Group Affiliates, Inc.:

    

    
      	
               
      

            	
              •

            	
              (i)
      if Actual EBITDA for such fiscal year is less than ninety percent
      (90%) of the Target EBITDA for such fiscal year,
  zero;

            

    

    

    
      	
               
      

            	
              •

            	
              (ii)
      if Actual EBITDA for such fiscal year is equal to ninety percent
      (90%) of the Target EBITDA for such fiscal year, an amount equal to
      thirty-five percent (35%) of the Base
Salary;

            

    

    

    
      	
               
      

            	
              •

            	
              (iii)
      if Actual EBITDA for such fiscal year is more than ninety percent
      (90%) and less than one hundred percent (100%) of the Target EBITDA for
      such fiscal year, an amount equal to the sum of (A) thirty five percent
      (35%) of the Base Salary plus (B) the product of three and 50/100 percent
      (3.50%) of the Base Salary multiplied by the number of full percentage
      points by which Actual EBITDA exceeds ninety percent (90%) of the Target
      EBITDA; and

            

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    
      	
               
      

            	
              •

            	
              (iv)
      if Actual EBITDA for such fiscal year equals of exceeds one hundred
      percent (100%) of the Target EBITDA for such fiscal year, an amount equal
      to seventy percent (70%) of the Base
Salary

            

    

    

    3.           Paragraph
(e) of Schedule 1 of the Employment Agreement, containing the definition of
“Performance Bonus,” is hereby deleted in its entirety and replaced with the
following

     

    (i)           “Target EBITDA” means,
(a) for Encompass' 2009 fiscal year:

     

    
      	
               
      

            	
              ·

            	
              2008
      - $8,100,000

            

    

     

    
      	
               
      

            	
              ·

            	
              2009
      - $13,000,000

            

    

     

    and (b)
for each complete fiscal year of Encompass during the Term thereafter, an amount
to be determined by the Compensation Committee no later than 30 days after the
Board's approval of Encompass' budget for such fiscal year; provided, that if
Encompass or any of its subsidiaries in any fiscal year enters into any
extraordinary transaction, such as a business acquisition or disposition, the
Compensation Committee in the exercise of its sole discretion may, at any time
during such fiscal year, adjust upward or downward the Target EBITDA for such
fiscal year to take into account such extraordinary transaction.  The
Compensation Committee shall notify Executive of the Target EBITDA for any such
fiscal year promptly after determining such Target EBITDA.

    

    4.           Except
as amended hereby, all terms and conditions as set forth in the Employment
Agreement shall remain in full force and effect.

    

    5.           This
Amendment may be executed in a number of counterparts, each of which shall be an
original but all of which together shall constitute one instrument.

    

    [Signature
page follows]

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    

    IN WITNESS WHEREOF, the parties have
caused this Amendment to be executed as of the date first above
written.

    

    
      
        
          	 
      	
                  ENCOMPASS
      GROUP AFFILIATES, INC.

                
	 
      	 
      	 
      
	 
      	
                  By:

                	 
      
	 
      	 
      	
                  John
      E. Donahue

                
	 
      	 
      	
                  Vice
      -President & Chief Financial Officer

                
	 
      	 
      	 
      
	 
      	 
      
	 
      	
                  STEPHEN
      J. MILLERExhibit
10.15

     

    Unofficial Summary Translation

     

    Shandong
University

    

    Laiyang
Jiangbo Pharmaceuticals Co, Ltd

    

    Technology
Cooperation Agreement

    

    September
16, 2007

    

    Cooperation
Agreement

    

    Biochemistry
and Biotechnology Research Institute of Pharmaceuticals Institute of Shandong
University (Party A) has great talent and technology strength and specialized
in drug research and development. To better utilize all the favorable
circumstances, better transform results of technology research, and provide
better environments for talent training and practice, it should timely seek to
cooperate with enterprises with certain advantages and fundamentals to
accomplish win-win situations

    

    Laiyang
Jiangbo Pharmaceuticals Co, Ltd (Party B) is a pharmaceutical manufacture
company and, to future develop itself, it shall closely rely on advanced science
and related technology and It actively cooperates with related scientific
research institutions to improve its research and development
capability.

    

    Party A
and Party B reached the agreement and made the follow contractual terms based on
the mutual benefits of both parties:

    

    
      	
              A.

            	
              Main
      content of the contract.

            

    

    

    Both
parties will closely cooperate on production development, technological
development, personnel training and transformations of scientific and
technological achievements in the field of biochemical and biological drugs
area.

    

    B.
Responsibilities and obligations of both parties

    
      	
              a.

            	
              Party
      A

            

    

    
      	
              1.

            	
              Shall
      provide all technical services, cooperate with Party B to establish
      projects and actively apply for related scientific and technological
      funding with party B.

            

    

    
      	
              2.

            	
              Develop
      new products with party B.

            

    

    
      	
              3.

            	
              Train
      technical personnel for Party B.

            

    

    
      	
              4.

            	
              Actively
      provide information related to technological research achievements and
      products information to Party B.

            

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      	
              5.

            	
              Shall
      help Party B to timely solve technological problems encountered during
      production and research process.

            

    

    

    
      	
              b.

            	
              Party
      B

            

    

    
      	
              1.

            	
              Shall
      be responsible for provide funding needed for the essential research
      work for the research and development projects established by both
      parties.

            

    

    
      	
              2.

            	
              Shall
      pay for all the expenses included necessary labor fees incurred by
      Party A for servicing Party B.

            

    

    
      	
              3.

            	
              Pay
      the annual payment of RMB 24,000,000 as research and development fund
      to Party A.

            

    

    
      	
              4.

            	
              Coordinate
      work with Party A actively.

            

    

    
      	
              5.

            	
              Provides necessary
      conditions for the research and intern work for undergraduate and
      graduate students from Party A, including foods and
      accommodations.

            

    

    

    
      	
            	
              C.

            	
              Distribution
      of property rights and project
outcomes

            

    

    
      	
              1.

            	
              Results
      of project established by both parties and the project funding was
      provided by Party B shall belong to both Party A and Party B with
      primarily ownership belongs to Party B. The profit shall be shared by both
      parties according to certain percentages (Separate agreement will be
      signed to determine profit sharing percentage) after the research
      outcomes are transformed into production. If Party A provides research
      results on its own, both parties shall establish agreements for the
      ownership of the property right and
outcomes.

            

    

    
      	
              2.

            	
              The
      spending of technology development funds planned by both parties and
      obtained by Party B from related government departments shall be discussed
      and agreed based on tasks and responsibilities of each
    party.

            

    

    

    
      	
              
              

            	
              D.

            	
              Funding
      and payment

            

    

    
      	
              1.

            	
              After
      the contract is signed and research topics are established by both
      parties, Party B shall provide research and development funding to Party A
      in various phases (Basically RMB 2,000,000 per
  month).

            

    

    
      	
              2.

            	
              Party
      B shall pay Party A RMB 24,000,000 annually for research and
      development funding. First payment shall be committed within ten
      days after the signing of the agreement. Monthly payment shall be due
      at the end of the month.

            

    

    

    
      	
              
              

            	
              E.

            	
              Breach
      of Agreement

            

    

    Neither
side shall disclose information related to production, project
technological documentation owned by both parties to a third party. The
party breaches the contract shall pay for the compensation for the economic loss
of the other party. Both parties shall carry out their own responsibilities
and obligations after the agreement is signed. The other party has the right for
termination if one party breaches the contract.

    

    
      	
               

            	
              F.

            	
              Others

            

    

    
      	
              1.

            	
              The
      contract becomes effective after it’s signed. Matters not mentioned herein
      shall be decided through negotiation between both parties to reach a
      decision.

            

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    
      	
              2.

            	
              This
      agreement shall be valid for a period of three
  years.

            

    

    
      	
              3.

            	
              This
      agreement has two copies, one each for both
  parties.

            

    

    

    School of
Pharmacy, Shandong University (Party A) (Seal)

    Representative:

    September
16, 2007

    

    Laiyang
Jiangbo Pharmaceuticals Co, Ltd (Part B) (Seal)

    Representative:

    

    September
16, 2007

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]